OTCMKTS:MKGAF

MERCK Kommanditgesellschaft auf Aktien - MKGAF Stock Forecast, Price & News

$189.25

+3.60 (+1.94%)

(As of 08/8/2022 12:00 AM ET)

Add

Compare

Today's Range: $189.25
▼
$191.97
50-Day Range: $162.53
▼
$191.64
52-Week Range: $162.20
▼
$264.40

Volume: 150 shs
Average Volume: 247 shs
Market Capitalization: $24.46 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKGAF) Stock

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

Receive MKGAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MERCK Kommanditgesellschaft auf Aktien and its competitors with MarketBeat's FREE daily newsletter.

MKGAF Stock News Headlines

July 29, 2022 | americanbankingnews.com

Analysts Set Expectations for MERCK Kommanditgesellschaft auf Aktien's Q2 2022 Earnings (OTCMKTS:MKGAF)

July 21, 2022 | americanbankingnews.com

Reviewing MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKGAF) and InflaRx (NASDAQ:IFRX)

July 20, 2022 | americanbankingnews.com

Short Interest in MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKGAF) Increases By 48.5%

July 13, 2022 | finance.yahoo.com

Micron to Select Athinia™ for Pioneering Data Collaboration

May 14, 2022 | markets.businessinsider.com

DGAP-DD: Merck KGaA english

May 12, 2022 | seekingalpha.com

MERCK Kommanditgesellschaft auf Aktien Non-GAAP EPS of €2.41, revenue of €5.2B; updates FY22 guidance

March 17, 2021 | finance.yahoo.com

Germany's Merck in fresh investment to make bioreactor gear in France

August 7, 2020 | feeds.marketwatch.com

Gilead's remdesivir to be tested with Merck KGaA's interferon vs. COVID by NIH

March 2, 2020 | finance.yahoo.com

ERBITUX® Approved for First-line Use in China in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)

January 22, 2020 | finance.yahoo.com

Does MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) CEO Pay Matter?

January 9, 2020 | seekingalpha.com

Merck KGaA to reconsider selling allergy business - Bloomberg

October 1, 2019 | www.businesswire.com

Versum Materials Announces China Antitrust Clearance of Merger with Merck KGaA, Darmstadt, Germany; Announces Expected Closing Date

August 8, 2019 | feeds.reuters.com

Merck KGaA's Q2 profit bolstered by drug milestone payments

August 8, 2019 | feeds.reuters.com

UPDATE 1-Merck KGaA's profit bolstered by lab supplies, drug milestone payments

May 14, 2019 | feeds.reuters.com

Merck KGaA sees currencies supporting 2019 outlook

April 12, 2019 | feeds.benzinga.com

Merck KGaA Signs Versum Buyout Deal; Entegris Receives Termination Payment

April 12, 2019 | feeds.reuters.com

Merck KGaA agrees $6.5 bln takeover of Versum

April 8, 2019 | feeds.reuters.com

UPDATE 2-Merck KGaA wins Versum's support for sweetened $6.5 bln offer

March 30, 2019 | seekingalpha.com

FDA OKs Merck KGaA's MS med Mavenclad

March 29, 2019 | feeds.reuters.com

UPDATE 3-Versum opens books, begins to warm to rival suitor Merck KGaA

March 26, 2019 | feeds.reuters.com

UPDATE 3-Merck KGaA goes hostile in $5.9 bln Versum takeover battle

March 12, 2019 | feeds.reuters.com

Merck KGaA calls on Versum investors to vote down Entegris merger

March 5, 2019 | feeds.reuters.com

UPDATE 1-Merck KGaA urges Versum shareholders to support takeover bid

March 1, 2019 | feeds.reuters.com

UPDATE 1-Versum Materials rejects Merck KGaA's unsolicited offer

February 27, 2019 | feeds.reuters.com

Germany's Merck makes $5.9 billion cash counterbid for Versum

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive MKGAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MERCK Kommanditgesellschaft auf Aktien and its competitors with MarketBeat's FREE daily newsletter.

MKGAF Company Calendar

Last Earnings: 5/12/2022
Today: 8/09/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:MKGAF
CUSIP: N/A
CIK: N/A
Web: www.merckgroup.com
Phone: 496151720
Fax: 49-61-5172-2000
Employees: 61,508
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $3.61 billion
Net Margins: 15.80%
Pretax Margin: 20.11%
Return on Equity: 17.71%
Return on Assets: 8.51%

Debt

Debt-to-Equity Ratio: 0.36
Current Ratio: 1.09
Quick Ratio: 0.68

Sales & Book Value

Annual Sales: $23.29 billion
Price / Sales: 1.05
Cash Flow: $51.85 per share
Price / Cash Flow: 3.65
Book Value: $196.05 per share
Price / Book: 0.97

Miscellaneous

Outstanding Shares: 129,240,000
Free Float: N/A
Market Cap: $24.46 billion
Optionable: Not Optionable
Beta: 0.94

Key Executives

Ms. Belen Garijo Lopez M.D. (Age 62)
Chair of Exec. Board & CEO
Comp: $5.71M
Dr. Marcus Kuhnert (Age 54)
CFO & Member of Exec. Board
Comp: $4.47M
Dr. Kai Beckmann (Age 57)
CEO of Electronics & Member of the Exec. Board
Comp: $4.5M
Mr. Peter Guenter (Age 60)
CEO of Healthcare Bus. & Member of Exec. Board
Comp: $2.21M
Dr. Matthias J. Heinzel (Age 55)
CEO of Life Science Sector & Member of Exec. Board
Comp: $1.68M
Mr. Gerhard Schmitz (Age 59)
Head of Global Accounting
Mr. Dirk Toepfer
Chief Information Officer
Mr. Constantin Fest (Age 45)
Head of Investor Relations
Dr. Friederike Rotsch (Age 50)
Group Gen. Counsel and Head of Group Legal & Compliance
Ms. Barbara Weiland (Age 48)
Chief Compliance Officer

Key Competitors

View All Competitors

MKGAF Stock - Frequently Asked Questions

How has MERCK Kommanditgesellschaft auf Aktien's stock price performed in 2022?: MERCK Kommanditgesellschaft auf Aktien's stock was trading at $261.50 at the beginning of 2022. Since then, MKGAF stock has decreased by 27.6% and is now trading at $189.25.
View the best growth stocks for 2022 here.
Are investors shorting MERCK Kommanditgesellschaft auf Aktien?: MERCK Kommanditgesellschaft auf Aktien saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 504,700 shares, an increase of 48.5% from the June 15th total of 339,800 shares. Based on an average daily volume of 700 shares, the short-interest ratio is currently 721.0 days.
View MERCK Kommanditgesellschaft auf Aktien's Short Interest.
How were MERCK Kommanditgesellschaft auf Aktien's earnings last quarter?: MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKGAF) announced its quarterly earnings results on Thursday, May, 12th. The company reported $2.70 earnings per share (EPS) for the quarter. The company earned $5.83 billion during the quarter. MERCK Kommanditgesellschaft auf Aktien had a net margin of 15.80% and a trailing twelve-month return on equity of 17.71%.
What is MERCK Kommanditgesellschaft auf Aktien's stock symbol?: MERCK Kommanditgesellschaft auf Aktien trades on the OTCMKTS under the ticker symbol "MKGAF."

How do I buy shares of MERCK Kommanditgesellschaft auf Aktien?: Shares of MKGAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is MERCK Kommanditgesellschaft auf Aktien's stock price today?: One share of MKGAF stock can currently be purchased for approximately $189.25.
How much money does MERCK Kommanditgesellschaft auf Aktien make?: MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKGAF) has a market capitalization of $24.46 billion and generates $23.29 billion in revenue each year.
How many employees does MERCK Kommanditgesellschaft auf Aktien have?: MERCK Kommanditgesellschaft auf Aktien employs 61,508 workers across the globe.
How can I contact MERCK Kommanditgesellschaft auf Aktien?: MERCK Kommanditgesellschaft auf Aktien's mailing address is Frankfurter Strasse 250, Darmstadt 2M, 64293. The official website for the company is www.merckgroup.com. The company can be reached via phone at 496151720, via email at investor.relations@merck.de, or via fax at 49-61-5172-2000.

This page (OTCMKTS:MKGAF) was last updated on 8/9/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources